Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(10%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
5
50%
Ph phase_2
4
40%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
4(40.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(8)
Other(1)

Detailed Status

Completed8
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (40.0%)
Phase 41 (10.0%)
N/A5 (50.0%)

Trials by Status

completed880%
active_not_recruiting110%
unknown110%

Recent Activity

1 active trials
Showing 5 of 10
completedphase_2

Evaluation of AMG 714 for Vitiligo

NCT04338581
active_not_recruitingnot_applicable

The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)

NCT05704205
completedphase_2

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo

NCT05247489
completedphase_2

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

NCT05298033
completednot_applicable

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

NCT04872257
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04338581Phase 2

Evaluation of AMG 714 for Vitiligo

Completed
NCT05704205Not Applicable

The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)

Active Not Recruiting
NCT05247489Phase 2

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo

Completed
NCT05298033Phase 2

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Completed
NCT04872257Not Applicable

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

Completed
NCT03155698Not Applicable

Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma

Unknown
NCT02552316Not Applicable

Psoriasis Microbiome and Phototherapy

Completed
NCT03123016Phase 2

Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo

Completed
NCT01553058Phase 4

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Completed
NCT00419406Not Applicable

Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis

Completed

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10